Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
300966 Hubei Goto Biopharm
- 16.65
- +0.35+2.15%
Market Closed Dec 27 15:00 CST
1.92BMarket Cap-137.60P/E (TTM)
16.70High16.15Low18.25KlotVolume16.34Open16.30Pre Close30.21MTurnover2.43%Turnover Ratio83.25P/E (Static)115.28MShares25.6852wk High2.28P/B1.25BFloat Cap12.0152wk Low19.56Limit Up75.13MShs Float79.83Historical High13.04Limit Down3.37%Amplitude12.01Historical Low0.02Dividend TTM16.56Avg Price7.55KlotAsk0.10%Div YieldTTM100Lot Size10.39KlotBid
Hubei Goto Biopharm Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 12.36%353.64M | 13.40%220.96M | 22.01%128.88M | -8.65%482.82M | -13.90%314.75M | -17.40%194.85M | 6.54%105.63M | -8.24%528.51M | 1.74%365.58M | -11.73%235.9M |
| Refunds of taxes and levies | 30.76%60.75M | -46.72%17.82M | 235.62%9.19M | 95.09%54.1M | 691.44%46.46M | 568.67%33.45M | -13.24%2.74M | 379.25%27.73M | 93.19%5.87M | 783.78%5M |
| Cash received relating to other operating activities | 490.88%75.55M | 234.10%31.75M | 53.57%19.15M | -64.72%22.44M | -78.47%12.79M | -81.79%9.5M | -61.75%12.47M | -15.23%63.6M | 225.47%59.4M | 393.32%52.17M |
| Cash inflows from operating activities | 31.00%489.94M | 13.76%270.53M | 30.11%157.22M | -9.76%559.36M | -13.20%373.99M | -18.86%237.81M | -10.43%120.84M | -5.62%619.84M | 13.20%430.85M | 5.27%293.07M |
| Goods services cash paid | -0.38%278.7M | -21.62%170.64M | -0.72%145.84M | -36.21%343.41M | -19.56%279.77M | -8.40%217.72M | 6.25%146.9M | 10.73%538.36M | 8.82%347.81M | 7.29%237.69M |
| Staff behalf paid | 9.15%49.87M | 9.09%33.16M | 2.09%17.72M | 22.08%62.44M | 28.08%45.69M | 20.12%30.39M | 18.62%17.36M | 31.46%51.15M | 18.44%35.67M | 33.41%25.3M |
| All taxes paid | 7.02%17.93M | -25.12%11.31M | -22.23%5.5M | 8.07%15.05M | 14.24%16.76M | 5.66%15.1M | 91.78%7.07M | -39.75%13.93M | -12.36%14.67M | -13.62%14.29M |
| Cash paid relating to other operating activities | 124.18%50.15M | 52.12%21.31M | 79.46%12.38M | 73.88%70.32M | -31.24%22.37M | -51.95%14.01M | -53.65%6.9M | -19.99%40.44M | 152.00%32.53M | 88.96%29.15M |
| Cash outflows from operating activities | 8.80%396.66M | -14.72%236.42M | 1.80%181.45M | -23.71%491.22M | -15.35%364.59M | -9.53%277.22M | 3.95%178.23M | 7.54%643.87M | 13.53%430.68M | 12.47%306.44M |
| Net cash flows from operating activities | 891.96%93.28M | 186.55%34.11M | 57.80%-24.22M | 383.45%68.13M | 5,680.24%9.4M | -194.95%-39.42M | -56.99%-57.39M | -141.44%-24.04M | -86.74%162.68K | -325.36%-13.36M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | --15.02M | ---- | ---- | ---- |
| Cash received from returns on investments | --0 | --0 | ---- | 3,718.70%8.94K | 3,712.02%8.94K | 3,718.70%8.94K | --575.11 | --234.12 | --234.53 | --234.12 |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --103.9K | --103.9K | 321.30%98.9K | ---- | --0 | --0 | --23.48K | 460.63%133.5K | --133.5K | ---- |
| Cash received relating to other investing activities | -100.00%57.93 | --0 | ---- | 33,391.27%34.06M | 44,164.20%45.02M | 24,500.50%25.02M | ---- | --101.71K | --101.71K | --101.71K |
| Cash inflows from investing activities | -99.77%103.96K | -99.58%103.9K | -99.34%98.9K | 14,371.86%34.07M | 19,025.63%45.03M | 24,452.77%25.03M | --15.04M | 736.02%235.45K | --235.45K | --101.95K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 1.08%328.95M | -16.77%177.35M | -56.28%58.23M | 0.32%409.25M | -1.52%325.45M | 67.38%213.09M | 160.09%133.21M | 348.90%407.94M | 421.55%330.48M | 196.74%127.31M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 133.33%33.6M | 104.88%33.6M | 0.00%14.4M |
| Cash paid relating to other investing activities | --0 | --0 | ---- | 81.11%27.17M | 169,104.74%30M | --30M | --30M | 14,915.03%15M | -82.27%17.73K | ---- |
| Cash outflows from investing activities | -7.45%328.95M | -27.04%177.35M | -64.32%58.23M | -4.41%436.42M | -2.37%355.45M | 71.55%243.09M | 148.73%163.21M | 333.25%456.54M | 355.89%364.1M | 146.87%141.71M |
| Net cash flows from investing activities | -5.94%-328.85M | 18.72%-177.25M | 60.77%-58.13M | 11.82%-402.35M | 14.69%-310.42M | -53.99%-218.06M | -125.81%-148.16M | -332.87%-456.3M | -355.59%-363.86M | -146.69%-141.6M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --24.5M | --24.5M | ---- | -39.51%19.6M | --0 | --0 | ---- | -85.57%32.4M | -84.58%32.4M | -85.88%29.4M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --24.5M | ---- | ---- | -39.51%19.6M | ---- | ---- | ---- | 98.53%32.4M | ---- | --29.4M |
| Cash from borrowing | 108.52%586.17M | 105.45%411.67M | -33.27%87M | -66.11%323.2M | -49.45%281.11M | -59.00%200.38M | -20.98%130.38M | 495.98%953.57M | 297.20%556.08M | 392.31%488.7M |
| Cash received relating to other financing activities | ---- | ---- | ---- | -99.78%20.54K | ---- | ---- | ---- | 185.32%9.13M | ---- | --2.75M |
| Cash inflows from financing activities | 117.23%610.67M | 117.67%436.17M | -33.27%87M | -65.55%342.82M | -52.23%281.11M | -61.53%200.38M | -28.25%130.38M | 156.68%995.1M | 66.50%588.48M | 69.42%520.85M |
| Borrowing repayment | 30.72%377.1M | -39.54%132.1M | -66.42%38.62M | 27.72%319.88M | 82.93%288.48M | 118.60%218.48M | 79.37%115M | 59.76%250.44M | 3.24%157.7M | 10.41%99.95M |
| Dividend interest payment | 22.19%13.02M | 5.83%8.22M | -62.61%3.09M | -77.35%6.09M | -55.82%10.65M | -65.62%7.76M | 166.82%8.28M | 255.18%26.91M | 317.62%24.11M | 580.61%22.58M |
| Cash payments relating to other financing activities | -46.40%671.31K | 49.18%671.31K | ---- | -71.91%1.25M | -90.86%1.25M | -80.70%450K | -84.37%250K | -72.76%4.45M | -18.70%13.71M | -80.63%2.33M |
| Cash outflows from financing activities | 30.09%390.79M | -37.81%140.99M | -66.23%41.71M | 16.12%327.22M | 53.64%300.39M | 81.56%226.69M | 79.51%123.53M | 55.97%281.8M | 11.48%195.52M | 17.92%124.86M |
| Net cash flows from financing activities | 1,240.69%219.88M | 1,221.66%295.18M | 561.08%45.29M | -97.81%15.59M | -104.91%-19.28M | -106.65%-26.32M | -93.93%6.85M | 244.58%713.3M | 120.67%392.97M | 96.48%395.99M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 1,418.76%1.1M | 550.53%1M | 1,346.65%271.08K | -215.46%-321.14K | -122.35%-83.66K | -490.14%-222.09K | 151.23%18.74K | 163.68%278.15K | 197.80%374.32K | 117.10%56.93K |
| Net increase in cash and cash equivalents | 95.45%-14.59M | 153.89%153.05M | 81.48%-36.8M | -236.75%-318.94M | -1,180.76%-320.38M | -217.81%-284.01M | -1,961.52%-198.69M | 46.54%233.23M | -70.07%29.64M | 61.00%241.08M |
| Add:Begin period cash and cash equivalents | -76.83%96.21M | -76.83%96.21M | -76.82%96.22M | 128.21%415.15M | 128.21%415.15M | 128.21%415.15M | 128.21%415.15M | 699.27%181.92M | 699.27%181.92M | 699.27%181.92M |
| End period cash equivalent | -13.88%81.62M | 90.07%249.25M | -72.55%59.43M | -76.83%96.21M | -55.20%94.77M | -69.00%131.14M | 12.39%216.46M | 128.21%415.15M | 73.67%211.56M | 145.21%422.99M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
